Insider Transactions in Q4 2024 at Maxcyte, Inc. (MXCT)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2024
|
Stanley C Erck |
SELL
Open market or private sale
|
Direct |
47,689
-15.05%
|
$143,067
$3.72 P/Share
|
|
Nov 01
2024
|
Stanley C Erck |
BUY
Exercise of conversion of derivative security
|
Direct |
47,689
+13.08%
|
$0
$0.04 P/Share
|
|
Oct 28
2024
|
John Joseph Johnston |
SELL
Open market or private sale
|
Direct |
3,000
-2.07%
|
$9,000
$3.72 P/Share
|
|
Oct 28
2024
|
John Joseph Johnston |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+2.03%
|
$6,000
$2.93 P/Share
|
|
Oct 14
2024
|
Cynthia Collins |
BUY
Grant, award, or other acquisition
|
Direct |
51,679
+50.0%
|
-
|
|
Oct 02
2024
|
Stanley C Erck |
SELL
Open market or private sale
|
Direct |
21,607
-7.43%
|
$64,821
$3.71 P/Share
|
|
Oct 02
2024
|
Stanley C Erck |
BUY
Exercise of conversion of derivative security
|
Direct |
21,607
+6.92%
|
$0
$0.04 P/Share
|
|
Oct 01
2024
|
Stanley C Erck |
SELL
Open market or private sale
|
Direct |
26,082
-8.84%
|
$78,246
$3.78 P/Share
|
|
Oct 01
2024
|
Stanley C Erck |
BUY
Exercise of conversion of derivative security
|
Direct |
26,082
+8.12%
|
$0
$0.04 P/Share
|